β-Indolyloxy Functionalized Aspartate Analogs as Inhibitors of the Excitatory Amino Acid Transporters (EAATs)
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
β-Indolyloxy Functionalized Aspartate Analogs as Inhibitors of the Excitatory Amino Acid Transporters (EAATs). / Liu, Na; Jensen, Anders A.; Bunch, Lennart.
In: ACS Medicinal Chemistry Letters, Vol. 11, No. 11, 2020, p. 2212-2220.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - β-Indolyloxy Functionalized Aspartate Analogs as Inhibitors of the Excitatory Amino Acid Transporters (EAATs)
AU - Liu, Na
AU - Jensen, Anders A.
AU - Bunch, Lennart
PY - 2020
Y1 - 2020
N2 - The excitatory amino acid transporters (EAATs) mediate uptake of the major excitatory neurotransmitter L-glutamate (Glu). The essential functions governed by these transporters in regulating the central Glu level make them interesting therapeutic targets in a wide range of neurodegenerative and psychiatric disorders. L-Aspartate (Asp), another EAAT substrate, has served as a privileged scaffold for the development of EAAT inhibitors. In this study, we designed and synthesized the first beta-indolyloxy Asp analogs 15a-d with the aim to probe a hitherto unexplored adjacent pocket to the substrate binding site. The pharmacological properties of 15a-d were characterized at hEAAT1-3 and rEAAT4 in a conventional [H-3]-D-Asp uptake assay. Notably, thiophene analog 15b and the Para-trifluoromethyl phenyl analog 15d were found to be hEAAT1,2-preferring inhibitors exhibiting IC50 values in the high nanomolar range (0.21-0.71 mu M) at these two transporters versus IC50 values in the low micromolar range at EAAT3,4 (1.6-8.9 mu M). In summary, the results presented herein open up for further structure-activity relationship studies of this new scaffold.
AB - The excitatory amino acid transporters (EAATs) mediate uptake of the major excitatory neurotransmitter L-glutamate (Glu). The essential functions governed by these transporters in regulating the central Glu level make them interesting therapeutic targets in a wide range of neurodegenerative and psychiatric disorders. L-Aspartate (Asp), another EAAT substrate, has served as a privileged scaffold for the development of EAAT inhibitors. In this study, we designed and synthesized the first beta-indolyloxy Asp analogs 15a-d with the aim to probe a hitherto unexplored adjacent pocket to the substrate binding site. The pharmacological properties of 15a-d were characterized at hEAAT1-3 and rEAAT4 in a conventional [H-3]-D-Asp uptake assay. Notably, thiophene analog 15b and the Para-trifluoromethyl phenyl analog 15d were found to be hEAAT1,2-preferring inhibitors exhibiting IC50 values in the high nanomolar range (0.21-0.71 mu M) at these two transporters versus IC50 values in the low micromolar range at EAAT3,4 (1.6-8.9 mu M). In summary, the results presented herein open up for further structure-activity relationship studies of this new scaffold.
KW - EAAT inhibitors
KW - TBOA analogs
KW - aspartate analogs
KW - glutamate transporters
U2 - 10.1021/acsmedchemlett.0c00342
DO - 10.1021/acsmedchemlett.0c00342
M3 - Journal article
C2 - 33214831
VL - 11
SP - 2212
EP - 2220
JO - ACS Medicinal Chemistry Letters
JF - ACS Medicinal Chemistry Letters
SN - 1948-5875
IS - 11
ER -
ID: 253073260